Recipharm -Model SMI -Soft Mist Inhalers

SHARE

Soft mist inhalers (SMI) are a versatile technology suitable for the delivery of both small and complex large molecules, optimising lung deposition whilst minimising oropharyngeal deposition.

Most popular related searches

The Resyca (SMI) is a joint venture between Recipharm and Medspray that harnesses proprietary spray nozzle technology to deliver next-generation SMIs that deliver an aerosol from a liquid solution. 

This versatile technology is ideal for the delivery of both small and complex large molecules and is specially designed to optimise lung deposition whilst minimising oropharyngeal deposition. Resyca soft mist inhalers are available as single use disposable device or multiple use devices and feature a maximum fill volume of 1ml.

Key applications of the SMI technology include:

Fill before administration – Pulmospray™

  • Pulmospray™ is a disposable nebuliser system, a single-use, purely mechanical inhalation device ideal for delivering a consistent, full dose. Designed as a substitute to nebulisers in:
    • Clinical environments (e.g. COVID-19) 
    • Products requiring reconstitution 
    • Single-dose treatments 
    • Clinical trials, investigational drug products 

Pre-filled syringe inhaler (PFSI):

  • A PFSI is a purely mechanical inhalation device designed for the efficient inhalation of liquid drug solutions, while optimising convenience for patients.  

Our SMI platform can be used for:

  • Disposable device with integrated pre-filled cartridge  
  • Re-usable device with replaceable pre-filled drug cartridge